Malignant hematopoietic cell lines: In vitro models for the study of mast cell leukemia

Leukemia Research

Volumn 27, Issue 8, 2003, Pages 671-676

  Drexler, Hans G ^a   MacLeod, Roderick A F ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

Author keywords

Cell lines; Leukemia; Mast cells

Indexed keywords

BIOLOGICAL MARKER; CD34 ANTIGEN; STEM CELL FACTOR;

ADULT; CANCER CELL CULTURE; CANCER PATIENT; CANCER RESEARCH; CASE REPORT; CELL FUNCTION; CELL TYPE; CHROMOSOME ANALYSIS; COLONY FORMATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOCHEMISTRY; CYTOGENETICS; DISEASE MODEL; FEMALE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; MALE; MAST CELL LEUKEMIA; MOLECULAR DYNAMICS; PRIORITY JOURNAL; REVIEW; SARCOMA;

EID: 0038542929     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(03)00007-9     Document Type: Editorial

References (28)

1. Ehrlich P. Beiträge zur kenntnis der granulierten bindegewebszellen und der eosinophilen leukozyten. Arch. Anat. Physiol. 3:1879;166-169.
2. Galli S.J. Biology of disease: new insights into the "riddle of the mast cells". Microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest. 62:1990;5-33.
3. Denburg J.A. Basophil and mast cell lineages in vitro and in vivo. Blood. 79:1992;846-860.
4. Valent P., Bettelheim P. Cell surface structures on human basophils and mast cells: biochemical and functional chraracterization. Adv. Immunol. 52:1992;333-423.
5. Agis H., Beil W.J., Bankl H.C., Füreder W., Sperr W.R., Ghannadan M.et al. Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myelodysplastic syndromes: diagnostic role of cell-immunophenotyping. Leuk. Lymphoma. 22:1996;187-204.
6. Marone G, Lichtenstein LM, Galli SJ, editors. Mast Cells and Basophils. London: Academic Press, 2000.
7. Parwaresch M.R., Horny H.P., Lennert K. Tissue mast cells in health and disease. Path. Res. Pract. 179:1985;439-461.
8. Valent P., Horny H.P., Escribano L., Longley B.J., Li C.Y., Schwartz L.B.et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk. Res. 25:2001;603-625.
9. Sperr W.R., Horny H.P., Lechner K., Valent P. Clinical and biologic diversity of leukemias occurring in patients with mastocytosis. Leuk. Lymphoma. 37:2000;473-486.
10. Drexler H.G., Matsuo Y., MacLeod R.A.F. Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research. Leuk. Res. 24:2000;881-911.
11. Butterfield J.H., Weiler D., Dewald G., Gleich G.J. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk. Res. 12:1988;345-355.
12. Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, Beaven MA, et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and LAD 2 from a patient with mast cell sarcoma-leukemia: activation following aggregation of FcεRI or FcγRI. Leuk Res. 2003;27:677-82.
13. Drexler HG, editor. The Leukemia-Lymphoma Cell Line FactsBook. San Diego: Academic Press, 2000.
14. Nilsson G., Blom T., Kusche-Gullberg M., Kjellén L., Butterfield J.H., Sundström C.et al. Phenotypic characterization of the human mast-cell line HMC-1. Scand. J. Immunol. 39:1994;489-498.
15. Drexler HG, Dirks WG, MacLeod RAF, Quentmeier H, Steube KG, Uphoff CC, editors. DSMZ Catalogue of Human and Animal Cell Lines, 8th ed. Braunschweig, Germany, 2001.
16. Drexler H.G., Uphoff C.C., Dirks W.G., MacLeod R.A.F. Mix-ups and mycoplasma: the enemies within. Leuk. Res. 26:2002;329-333.
17. Drexler HG, Dirks WG, Matsuo Y, MacLeod RAF. False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia [in press].
18. Drexler H.G., Matsuo Y. Guidelines for the characterization and publication of human malignant hematopoietic cell lines. Leukemia. 13:1999;835-842.
19. Escribano L., Diaz-Agustin B., Bellas C., Navalon R., Nunez R., Sperr W.R.et al. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis. Leuk. Res. 25:2001;563-570.
20. Galli S.J., Tsai M., Wershil B.K. The c-kit receptor, stem cell factor, and mast cells: what each is teaching us about the others. Am. J. Pathol. 142:1993;965-974.
21. Furitsu T., Tsujimura T., Tono T., Ikeda H., Kitayama H., Koshimizu U.et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J. Clin. Invest. 92:1993;1736-1744.
22. Metcalfe D.D., Akin C. Mastocytosis: molecular mechanisms and clinical disease heterogeneity. Leuk. Res. 25:2001;577-582.
23. Longley B.J., Reguera M.J., Ma Y. Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy. Leuk. Res. 25:2001;571-576.
24. Romana S.P., Poirel H., Leconiat M., Flexor M.A., Mauchauffe M., Jonveaux P.et al. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood. 86:1995;4263-4269.
25. Bernard O.A., Busson-LeConiat M., Ballerini P., Mauchauffe M., Della Valle V., Monni R.et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32) is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia. 15:2001;1495-1504.
26. Sugita K., Kaneko T., Sekine Y., Taguchi N., Miyauchi J. Mast cell leukemia evolved from RAEB-T (5q-syndrome) in a 12-year-old girl. Rinsho Ketsueki. 37:1996;430-436.
27. MacLeod RAF, Drexler HG. Cytogenetic characterization of tumor cell lines. In: Langdon S, editor. Cancer Cell Culture - Methods and Protocols, Totowa, NJ: Humana Press, 2003 [in press].
28. Hayhoe FGJ, Flemans, editors. A Colour Atlas of Haematological Cytology. London: Wolfe Publication, 1992.